Ultrasonographic thyroid volume as a reliable prognostic index of radioiodine-131 treatment outcome in Graves' disease hyperthyroidism

Hormone and Metabolic Research

Volumn 35, Issue 8, 2003, Pages 492-497

  Gomez Arnaiz N ^a   Andia E ^a   Guma A ^a   Abos R ^a   Soler, J ^a   Gomez J M ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Anti thyroid peroxidase antibodies; Graves' hyperthyroidism; Prognostic factors; Radioiodine 131 therapy; Thyroid echogenicity; Thyroid volume; Treatment outcome TSH receptor antibodies

Indexed keywords

BIOLOGICAL MARKER; IODINE 131; LIOTHYRONINE; THYROID ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; ECHOGRAPHY; EUTHYROIDISM; FEMALE; FOLLOW UP; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; IMMUNOREACTIVITY; LIOTHYRONINE BLOOD LEVEL; LOGISTIC REGRESSION ANALYSIS; LOW DRUG DOSE; MALE; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; RELIABILITY; REMISSION; THYROID FUNCTION; THYROID WEIGHT; THYROTROPIN BLOOD LEVEL; TREATMENT OUTCOME;

EID: 0141675047     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-41807     Document Type: Article

References (28)

1. Kendall-Taylor P, Keir MJ, Ross WM. Ablative radioiodine therapy for hyperthyroidism. Long-term follow-up study. Br Med J 1984; 289: 361-363
2. Sridama V, McCornlck M, Kaplan EL, Fauchet R, DeGroot LJ. Long-term follow-up study of compensate low dose 1311 therapy for Graves' disease. N Engl J Med 1984; 16: 426-432
3. Goolden AWG, Stewart JSW. Long-term results from graded low-dose radioactive iodine therapy for thyrotoxicosis. Clin Endocrinol (Oxf) 1986; 24: 217-222
4. Franklyn JA, Daykin J, Drolc Z, Farmer M, Sheppard MC. Long-term follow-up of treatment of thyrotoxicosis by three different methods. Clin Endocrinol (Oxf) 1991; 34: 71-76
5. Nordike RA, Gilbert FI. Optimal iodine-131 dose for eliminating hyperthyroidism in Graves' disease. J Nucl Med 1991; 32: 487-496
6. Leisner B. Ultrasound evaluation of thyroid diseases. Horm Res 1987; 26: 33-41
7. Berghout A, Wiersinga WM, Smits NJ, Touber JL. The value of thyroid volume measured by ultrasonography in the diagnosis of goitre. Clin Endocrinol (Oxf) 1998; 28: 409-414
8. Aizawa Y, Yoshida K, Kaise N, Kaise K, Fukazawa H, Kiso Y. Long-term effects of radioiodine on thyrotropin receptor antibodies in Graves' disease. Clin Endocrinol (Oxf) 1995; 42: 517-522
9. Rieu M, Raynaud A, Richard A, Laplanche S, Sambor B, Berrod JL. Evidence for the effect of antibodies to TSH receptors on the thyroid ultrasonographic volume in patients with Graves' disease. Clin Endocrinol (Oxf) 1994; 41: 667-671
10. Murakami Y, Takamatsu J, Sakane S, Kurna K, Ohsawa N. Changes in thyroid volume in response to radioactive iodine for Graves' hyperthyroidism correlated with activity of thyroid-stimulating antibody and treatment outcome. J Clin Endocrinol Metab 1996; 81: 3257-3260
11. Leslie WD, Peterdy AE, Dupont JO. Radioiodine treatment outcomes in thyroid glands previously irradiated for Graves' hyperthyroidism. J Nucl Med 1988; 39: 712-716
12. Gómez N, Gómez JM, Orti A et al. Transient hypothyroidism after iodine-131 therapy for Graves' disease. J Nucl Med 1995; 36: 1539-1542
13. Brunn J, Block U, Ruf G, Bos L, Kunze W, Scriba PC. Volumetrie der Schilddrüsenlappen mittels realtime Sonographie. Dtsch Med Wochenschr 1981; 106: 1338-1340
14. Gómez JM, Maravall FJ, Gómez N, Gumà A, Soler J. Determinants of thyroid volume as measured bu ultrasonography in healthy adults randomly selected. Clin Endocrinol (Oxf) 2000; 53: 629-634
15. Gómez-Arnaiz N, Gómez Sáez JM, Orti Llaveria A, Gavaldà Mestre L, Mairal Pairó L. Resultados del tratamiento de la enfermedad de Graves Basedow con 131I a dosis bajas calculadas. Rev Clin Esp 1998; 198: 57-60
16. Gómez JM, Gómez N, Amat M, Biondo S, Rafecas A, Jaurrieta E, Soler J. Hypothyroidism after iodine-131 or surgical therapy for Graves' disease hyperthyroidism. Ann Endocrinol 2000; 61: 184-191
17. Virgili N, Gómez JM, Montaña E, Soler J, Castells M, Roca M. Short-term follow-up of patients with Graves' disease treated with I131. The prevalence of transient hypothyroidism. Rev Clin Esp 1988; 183: 300-303
18. Müller-Gartner HW, Schneider C, Schroeder S. Autoimmune-resistance in Graves' disease tissues: indication of a structural and functional heterogenicity. Acta Endocrinol (Copenh) 1986; 113: 233-241
19. Chiovato L, Fiore E, Vittl P et al. Outcome of thyroid function in Graves' patients with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine- induced thyroid damage. J Clin Endocrinol Metab 1998; 83: 40-46
20. Tsuruta M, Nagayama Y, Yokoyama N, Izumi M, Nagataki S. Long-term follow-up studies on iodine-131 treatment of hyperthyroid Graves' disease based on the measurement of thyroid volume by ultrasonography. Ann Nucl Med 1993; 7: 193-197
21. Marcocci C, Gianchecchi O, Masini I et al. A reappraisal of the role of methimazole and other factors on the efficacy and outcome of radio-iodine therapy of Graves' hyperthyroidism. J Endocrinol Inves 1990; 13: 513-520
22. Ralls PW, Mayekawa OS, Lee KP et al. Color-flow doppler sonography in Graves' disease: "Thyroid inferno". Am J Roentg 1988; 150: 781-784
23. Vitti P, Raga T, Mancusi F et al. Thyroid hypoechogenic pattern at ultrasanography as a tool for predicting recurrence of hyperthyroidism after medical treatment in patients with Graves' disease. Acta Endocrinol (Copenh) 1992; 126: 128-131
24. Zingrillo M, D'Aloiso L, Ghíggi MR et al. Thyroid hypoechogenicity after methimazole withdrawal in Graves' disease: a useful index for predicting recurrence? Clin Endocrinol (Oxf) 1996; 45: 201-206
25. Macchia E, Concetti R, Borgoni F, Cetani F, Fenzi CF, Pinchera A. Assays of TSH-receptor antibodies in 576 patients with various thyroid disorders: their influence, significance and clinical usefulness. Autoimmunity 1989; 3: 103-112
26. Ludgate ME, Vassart G. The thyrotropin receptor. Ball Clin Endocrinol Metab 1995; 9: 95-113
27. Okamoto Y, Hamada N, Fujisawa T et al. Why no simple relationship between thyroid peroxidase activity-inhibiting immunoglobulins and the thyroid function in autoimmune thyroid disease? Acta Endocrinol (Copenh) 1991; 124: 442-448
28. Vassart G, Dumont JE. The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocrin Rev 1992; 13: 569-611